Company Filing History:
2 out of 12 
2 out of 1,747 
1 out of 12 
Years Active: 2011-2013
Title: Mary M. Hulihan: Innovator in Neurodegenerative Disorder Research
Introduction
Mary M. Hulihan is a prominent inventor based in Atlanta, GA, known for her significant contributions to the field of neurodegenerative disorders. With a total of two patents to her name, she has made remarkable strides in understanding and treating conditions such as Parkinson's disease and Alzheimer's disease.
Latest Patents
Her latest patents focus on the KASPP (LRRK2) gene, which is crucial for the detection and treatment of neurodegenerative disorders. The invention details the production, biochemical characterization, and application of the KASPP gene, also known as LRRK2 (Leucine-Rich Repeat Kinase 2). This gene is associated with various neurodegenerative conditions, including sporadic Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, and other related disorders. The research highlights several polymorphisms and mutations in the KASPP/LRRK2 gene that are linked to Parkinson's disease.
Career Highlights
Mary has worked with esteemed institutions such as Eberhard Karls Universität Tübingen and the Mayo Foundation for Medical Education and Research. Her work has been instrumental in advancing the understanding of genetic factors in neurodegenerative diseases.
Collaborations
Throughout her career, Mary has collaborated with notable colleagues, including Thomas Meitinger and Tim Matthias Strom. These partnerships have further enriched her research and contributions to the field.
Conclusion
Mary M. Hulihan's innovative work in the realm of neurodegenerative disorders showcases her dedication to advancing medical science. Her patents and collaborations reflect her commitment to improving the lives of those affected by these challenging conditions.